Daily
No daily data
GENB | Generate BiomedicinesNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
Generate Biomedicines (GENB) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2026.
Price sits between the 50 and the 200 on the 4-hour.
Timeframe summary
Weekly
No weekly data
4-hour as of 3 Nov 13:30 ET
- Price
- between the two $13.88 vs 50 $13.56 / 200 $14.89
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 16 Oct 2026 · projected 29 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 16 Oct 2026 | 💀Death | 4-hour | 29 bars out | Not tested |
About GENB
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$15.5M
4-hour coverageYes, since Feb 2026
History on recordSince 2026
SectorHealthcare
Cap bandmid